Eozinofilni ezofagitis
Sažetak
Eozinofilni ezofagitis (EoE) je inflamatorno stanje koje se karakteriše intraepitelnom eozinofilnom infiltracijom praćenom disfunkcijom jednjaka. Patofiziološki mehanizam EoE još nije dobro poznat, postoji nekoliko faktora koji učestvuju u patogenezi, kao što su imunitet domaćina, faktori životne sredine i genetski faktori. Savremena dijagnostika EoE treba da obuhvati: kliničke manifestacije (disfunkcija jednjaka), biopsiju jednjaka sa najmanje 15 eozinofila po polju velikog uveličanja i odsustvo druge patologije koju karakteriše povećan broj eozinofila. Najčešći simptomi kod odraslih su disfagija, gorušica, zastoj hrane u jednjaku i bol u grudima. Deca se obično prezentuju mučninom i povraćanjem, anoreksijom, gorušicom, regurgitacijom, pečenjem u grudima i bolovima u stomaku. Endoskopski, pacijente sa EoE karakterišu uzdužne brazde (vertikalne linije, tamnije od okolne sluzokože), trahealizacija jednjaka (brojni transverzalni prstenovi, kao kod traheje), eksudat (beli plakovi), edem (smanjena vaskularizacija sluzokože), strikture i “crepe-paper” sluzokoža (krhkost sluzokože i kidanje tokom endoskopije). Histološke karakteristike EoE mogu se podeliti na major i minor kriterijume. Major kriterijumi uključuju: intraepitelnu infiltraciju eozinofilima (>15 eozinofila/HPF), eozinofilne mikroapscese (≥ 4 eozinofila u kolekciji), eozinofile koji zauzimaju spoljašnji sloj skvamoznog epitela, ljuštenje epitela i degranulaciju eozinofila. Minor kriterijumi uključuju: hiperplaziju bazalne zone epitela jednjaka, produženje epitelnih papila, intracelularni edem i subepitelnu fibrozu. Da bi se postavila adekvatna dijagnoza, treba isključiti sva ostala stanja povezana sa povećanim brojem eozinofila. Najčešća i najvažnija diferencijalna dijagnoza je gastroezofagealna refluksna bolest (GERB). Lečenje EoE obuhvata: inhibitore protonske pumpe (PPI), kortikosteroide (lokalne i sistemske), eliminacionu dijetu i dilataciju jednjaka.
Reference
1. Dellon ES, Hirano I. Epidemiology and Natural History of Eosinophilic Esophagitis. Gastroenterology. 2018 Jan;154(2):319-332.e3.
2. Coakley G, Wang H, Harris NL. Intestinal eosinophils: multifaceted roles in tissue homeostasis and disease. Semin Immunopathol. 2021 Jun;43(3):307-317.
3. Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N et al. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018 Oct;155(4):1022-1033.e10.
4. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE et al. First International Gastrointestinal Eosinophil Research Symposium (FIGERS) Subcommittees. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007 Oct;133(4):1342-63.
5. Dellon ES, Kim HP, Sperry SL, Rybnicek DA, Woosley JT, Shaheen NJ. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc. 2014 Apr;79(4):577-85.e4.
6. Sperry SL, Crockett SD, Miller CB, Shaheen NJ, Dellon ES. Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc. 2011 Nov;74(5):985-91.
7. Hiremath GS, Hameed F, Pacheco A, Olive A, Davis CM, Shulman RJ. Esophageal Food Impaction and Eosinophilic Esophagitis: A Retrospective Study, Systematic Review, and Meta-Analysis. Dig Dis Sci. 2015 Nov;60(11):3181-93.
8. Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005 Dec;3(12):1198-206.
9. Lehman HK, Lam W. Eosinophilic Esophagitis. Pediatr Clin North Am. 2019 Oct;66(5):955-965.
10. Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology. 2014 Dec;147(6):1238-54.
11. Assa'ad AH, Putnam PE, Collins MH, Akers RM, Jameson SC, Kirby CL et al. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol. 2007 Mar;119(3):731-8.
12. Abonia JP, Wen T, Stucke EM, Grotjan T, Griffith MS, Kemme KA et al. High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. J Allergy Clin Immunol. 2013 Aug;132(2):378-86.
13. Erwin EA, James HR, Gutekunst HM, Russo JM, Kelleher KJ, Platts-Mills TA. Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2010 Jun;104(6):496-502.
14. Reed CC, Dellon ES. Eosinophilic Esophagitis. Med Clin North Am. 2019 Jan;103(1):29-42.
15. Kim HP, Vance RB, Shaheen NJ, Dellon ES. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol. 2012 Sep;10(9):988-96.e5.
16. Wojas O, Żalikowska-Gardocka M, Krzych-Fałta E, Samoliński B, Przybyłkowski A. Eosinophilic esophagitis: an interdisciplinary clinical problem. Postepy Dermatol Alergol. 2021 Feb;38(2):36-42.
17. Ristic N, Jankovic R, Dragutinovic N, Atanaskovic-Markovic M, Radusinovic M, Stevic M et al. Diagnosis of Eosinophilic Esophagitis in Children: A Serbian Single-Center Experience from 2010 to 2017. Med Princ Pract. 2019;28(5):449-456.
18. Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA; American College of Gastroenterology. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013 May;108(5):679-92.
19. Hogan SP, Mishra A, Brandt EB, Foster PS, Rothenberg ME. A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6681-6.
20. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011 Jul;128(1):3-20.
21. Lucendo AJ, Molina-Infante J, Arias Á, von Arnim U, Bredenoord AJ, Bussmann C et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J. 2017 Apr;5(3):335-358.
22. Muir A, Falk GW. Eosinophilic Esophagitis: A Review. JAMA. 2021 Oct 5;326(13):1310-1318.
23. Molina-Infante J, Bredenoord AJ, Cheng E, Dellon ES, Furuta GT, Gupta SK et al. PPI-REE Task Force of the European Society of Eosinophilic Oesophagitis (EUREOS). Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis. Gut. 2016 Mar;65(3):524-31.
24. Rank MA, Sharaf RN, Furuta GT, Aceves SS, Greenhawt M, Spergel JM et al. Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. Gastroenterology. 2020 May;158(6):1789-1810.e15.
25. Hirano I, Chan ES, Rank MA, Sharaf RN, Stollman NH, Stukus DR et al. AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2020 May;124(5):416-423.
26. Gonsalves N, Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012 Jun;142(7):1451-9.
27. Moawad FJ, Molina-Infante J, Lucendo AJ, Cantrell SE, Tmanova L, Douglas KM. Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis. Aliment Pharmacol Ther. 2017 Jul;46(2):96-105.